XEP-018

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameXEP-018
Drug Alias Nameconus consors venom (Atheris)XEP-018
ClassificationBiologics > Protein drugs > ToxinNatural product/ExtractBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionSodium channel protein type IV alpha subunit modulators
TargetsSodium channel protein type IV alpha subunit
Therapy Area/IndicationsPainAnesthesia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryWestern Europe
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAtheris Laboratories
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAtheris Laboratories
Active IndicationsN/A
Inactive IndicationsPainAnesthesia

Other Information

ATC CodeN/A
Related LinksN/A